MONITORMSGLP-1 CompoundingFeb 3, 2026

MS SB2544: Mississippi Active Pharmaceutical Ingredient Quality Assurance Act; enact to impose certain provisions for compounding.

New regulations could impact drug compounding for med spas.

What changed & why it matters

Med Spa Radar recorded state legislation in MS, dated February 3, 2026, in the GLP-1 Compounding category.

State legislation is where scope-of-practice, supervision, good-faith-exam, ownership, and med-spa-licensure rules change — the requirements that most directly govern who may perform aesthetic procedures and under what oversight. It is specific to MS, whose med-spa requirements are set by MS statute and its licensing boards — distinct from federal rules and from every other state.

Type
LegiScan
Jurisdiction
MS (state)
Category
GLP-1 Compounding
Recorded
February 3, 2026

What this means for your specific practice — the exact step to take, the deadline to calendar, or the supplier detail to check — is in the member "what to do" below. This page is the free record of what changed and why it matters.

What to do

Free weekly Brief

Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.

Members get the full “what to do” on every alert — in real time, for your states. Become a member →

LegiScan · primary source ↗

Related alerts

See all Mississippi med spa regulations →

Monitoring, not legal advice.